USPTO serial 79438380
VE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with VE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bruce Margulies
Bruce Margulies Margulies Law PLLC700 Market Street #218Chapel Hill, NC 27516United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical compounds, namely, raw materials for use in the manufacture of cosmetics and pharmaceuticals, namely, ACS-Anticytostressor, Adf-Oleile, Afron-22, Afrosalt, Alcoramnosan, Alutrat, Aminoefaderma-20 N-P, Arrectosina, Auxina Tricogena, Azamide, Braxicina N-P, Carbossalina, Cellosan, Cetacene, Cetasol-Velvet, Collagenon, Dacriosalt, Daucoil N-P, Dermonectin, Delta Rosa Moschata, Desadrops, Efaderma, Efaderma-F, Efadermasterolo, Elicrisina, Epch, Fenexol, Filagrinol, Frabes-Oil Dcg, Hexatrate, Hexatrate Al-F, Hyaluramine-S, Hydrofarv, Idroramnosan, Integrine-60, Iodotrat, Ipbs-F, Isocet, Isostearene, Isoxal-1, Isoxal-12, Isoxal-H, Ixol-2, Ixol-4, Ixol-6, Ixol-8, Ixolene-2, Ixolene-4, Ixolene-6, Ixolene-8, Kalixide Grassa, Kalixide-As, Kalixide Ct, Keratoplast, Keresine P-E, Lanolide, Lanolide-Extra, Lanolide-F5, Lipocerite, Lipofarv, Lipogelag, Lipophos, Liporamnosan, Lipotrophyne-A, Liquiritina, Lmb, Megasol 3d, Megasol E-Sink, Megasol M-Mod, Melibion, Myristamine, Nesatol, Nidaba-318, Nidaba-S, Octaprotein-Colloid, Oligoidyne-1-Complex, Oligoidyne-2-Complex, Osmopherine, Osmopherone-H, Osmopherone-L, Phytosqual, Phytosqual Hydrogen, Pme, Pme-1 N-P, Poliglicoleum, Poliglicoleum-G, Poliglicoleum-N, Ricino-Viscoil-N, Salycuminol, Sebopessina, Seboside, Sitostene, Skyline-F, Skyline-P, Syntesqual, Talcoseptic-C, Tensoil-N, Tergene-12, Thalaton, Thalaton P-F, Tricosolfan, Trilipidina, Trioxene-Lv, Undamide, Undebenzofene-C, Undebenzofene-C P-F, Undebenzofene-Hp, Undelene, Undenat, Undezin, Vaselide, Viscolene, Visonoil-R, Vyox, Vyox-G, Xalidrene, Xalifin-15, Xalifin-15 N-P, Zedomine-1-L, Zedomine-2-L, Zedomine-3-L, Hydroessentials, Lipoplastidines; Surfactants for use in the manufacture of cosmetic finished products; Emulsifiers for use in the manufacture of cosmetic finished products; Fats and oils for use in the manufacture of cosmetic finished products; Rheologic Additives for use in manufacture of cosmetic finished products; Antioxidants for use in manufacture of cosmetic finished products; antioxidants for use in the manufacture of cosmetics; Preservatives for use in manufacture of cosmetic finished products; preservatives for use in the pharmaceutical industry; Inorganic and Metallorganic active chemical ingredients for use in manufacture of cosmetic finished products; iodine for chemical purposes; iodised salts for use in manufacture of cosmetic finished products; plant-derived active chemical ingredients for use in manufacture of cosmetic finished products; plant extracts for use in the manufacture of cosmetics; essential oils for use in manufacture; active chemical ingredients for use in manufacture of cosmetic finished products; Active chemical ingredients for use in manufacture of finished cosmetic products. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 29, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 23, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 4, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 2, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 19, 2026 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 19, 2026 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Aug 19, 2026 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Jul 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 14, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 14, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 14, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 6, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 6, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 5, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 5, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 11, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 15, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 4, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |